Mark Lappe, Director, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), bought 62,134 shares at $6.85 ($418K) on 2008-10-27, disclosed to the SEC on 2008-10-27.
Open-market purchase of $418k RPRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.32 | 17,309 | $109K | 26.2% |
| 2 | $6.89 | 30,000 | $207K | 49.5% |
| 3 | $6.85 | 14,825 | $102K | 24.3% |
| Total | $6.72 avg | 62,134 | $418K | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |